The aim of this study was to evaluate the prevalence and genetic diversity of hepatitis B virus (HBV) and hepatitis C virus (HCV) in human immunodeficiency virus type 1 (HIV-1)-co-infected Venezuelan patients. The prevalence of HBV and HCV markers of infection in HIV-1 patients was 14 % for anti-hepatitis B core antigen, 3 % for hepatitis B surface antigen and 0.7 % for anti-HCV, respectively. HBV prevalence was higher than HCV, as expected for a country where sexual intercourse, not intravenous drug use, is the main mode of HIV-1 transmission. The HCV genotype distribution in HIV-1-co-infected patients was similar to that obtained in HCV-mono-infected patients, but genotype 1a was more frequent in HIV-1-infected patients. The HBV genotype distribution exhibited differences between mono-infected and HIV-1-co-infected individuals. HBV F3 was the most common subgenotype in both groups, followed by F1b in HIV-1 co-infection and F2 in HBV mono-infection. In addition, genotype G (single infection) was found in an HIV-1-co-infected individual. A high prevalence of occult HBV infection was detected in HIV-1-co-infected naïve patients (18 %), with F2 being the most common genotype (75 %). To the best of our knowledge, these results correspond to the first description of frequency and molecular characterization of HBV and HCV in HIV-1 Venezuelan patients.
AguilarM. S., CossonC., LoureiroC. L., DevesaM., MartínezJ., VillegasL., FloresJ., LudertJ. E., Alarcón de NoyaB. et al.2001; Prevalence of infection with hepatitis C virus in Venezuela, as assessed with an immuno-assay based on synthetic peptides. Ann Trop Med Parasitol 95:187–195 [View Article][PubMed]
AllenM. I., DeslauriersM., AndrewsC. W., TipplesG. A., WaltersK. A., TyrrellD. L., BrownN., CondreayL. D.Lamivudine Clinical Investigation Group1998; Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Hepatology 27:1670–1677 [View Article][PubMed]
AraujoN. M., Branco-VieiraM., SilvaA. C., PilottoJ. H., GrinsztejnB., de AlmeidaA. J., TrepoC., GomesS. A.2008; Occult hepatitis B virus infection in HIV-infected patients: evaluation of biochemical, virological and molecular parameters. Hepatol Res 38:1194–1203[PubMed]
BiswasS., CandottiD., AllainJ. P.2013; Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection. J Virol 87:7882–7892 [View Article][PubMed]
CainelliF.2013; Hepatitis C virus and human immunodeficiency virus transmission routes: Differences and similarities. World J Hepatol 5:234–236 [View Article][PubMed]
CardonaN. E., LoureiroC. L., GarzaroD. J., DuarteM. C., GarcíaD. M., PachecoM. C., CheminI., PujolF. H.2011; Unusual presentation of hepatitis B serological markers in an Amerindian community of Venezuela with a majority of occult cases. Virol J 8:527–534 [View Article][PubMed]
ChudyM., SchmidtM., CzudaiV., ScheiblauerH., NickS., MosebachM., HourfarM. K., SeifriedE., RothW. K. et al.2006; Hepatitis B virus genotype G monoinfection and its transmission by blood components. Hepatology 44:99–107 [View Article][PubMed]
DevesaM., LoureiroC. L., RivasY., MonsalveF., CardonaN., DuarteM. C., PobleteF., GutierrezM. F., BottoC., PujolF. H.2008; Subgenotype diversity of hepatitis B virus American genotype F in Amerindians from Venezuela and the general population of Colombia. J Med Virol 80:20–26 [View Article][PubMed]
El ChaarM., CandottiD., CrowtherR. A., AllainJ. P.2010; Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology 52:1600–1610 [View Article][PubMed]
GuteliusD., LiJ., WandsJ., TongS.2011; Characterization of the pleiotropic effects of the genotype G-specific 36-nucleotide insertion in the context of other hepatitis B virus genotypes. J Virol 85:13278–13289 [View Article][PubMed]
HuX., MargolisH. S., PurcellR. H., EbertJ., RobertsonB. H.2000; Identification of hepatitis B virus indigenous to chimpanzees. Proc Natl Acad Sci U S A 97:1661–1664 [View Article][PubMed]
HuangC. H., YuanQ., ChenP. J., ZhangY. L., ChenC. R., ZhengQ. B., YehS. H., YuH., XueY. et al.2012; Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol 57:720–729 [View Article][PubMed]
JaspeR. C., SulbaránY. F., SulbaránM. Z., LoureiroC. L., RangelH. R., PujolF. H.2012; Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates. Virol J 9:214–221 [View Article][PubMed]
KatoH., OritoE., GishR. G., SugauchiF., SuzukiS., UedaR., MiyakawaY., MizokamiM.2002; Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes (A through F). J Virol 76:6131–6137 [View Article][PubMed]
LemoineM., NayagamS., ThurszM.2013; Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. Future Virol 8:371–380 [View Article][PubMed]
MachadoI. V., del Pilar FortesM., Vargas-LovelleB., TrómpizA. C., LópezD. A., LeónR. V., SeniorM., DagherL., LópezC. E. et al.2010; Genotype F prevails in Venezuelan urban patients with chronic hepatitis B. Ann Hepatol 9:172–176[PubMed]
PereiraG. A., StefaniM. M., MartelliC. M., TurchiM. D., SiqueiraE. M., CarneiroM. A., MartinsR. M.2006; Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil. J Med Virol 78:719–723 [View Article][PubMed]
PujolF. H., LoureiroC. L.2007; Replacement of hepatitis C virus genotype 1b by genotype 2 over a 10-year period in Venezuela. J Clin Gastroenterol 41:518–520 [View Article][PubMed]
RangelH. R., GarzaroD., PujolF. H.2009; Genetic diversity of human immunodeficiency virus in the Americas, with emphasis on the Venezuelan epidemic. Interciencia 34:163–169 (in Spanish)
SucupiraM. V., MelloF. C., SantosE. A., NielC., RollaV. C., ArabeJ., GomesS. A.2006; Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations. Mem Inst Oswaldo Cruz 101:655–660 [View Article][PubMed]
SulbaránM. Z., Di LelloF. A., SulbaránY., CossonC., LoureiroC. L., RangelH. R., CantaloubeJ. F., CamposR. H., MoratorioG. et al.2010; Genetic history of hepatitis C virus in Venezuela: high diversity and long time of evolution of HCV genotype 2. PLoS ONE 5:e14315 [View Article][PubMed]